Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced Medical Solutions GroupCHIX:AMSL -0.09%77 Days Sales Outstanding is 68.38 as of Dec. 2025, which is 8% above its 10-year median of 63.20. GuruFocus rates CHIX:AMSL with a GF Score™ of 77/100 and a GF Value™ of £3.75 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks worse than 57.9% on this metric.
The historical rank and industry rank for Advanced Medical Solutions Group's Days Sales Outstanding or its related term are showing as below:
CHIX:AMSl'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.48 Med: 63.2 Max: 91.02
Current: 71.46
During the past 13 years, Advanced Medical Solutions Group's highest Days Sales Outstanding was 91.02. The lowest was 43.48. And the median was 63.20.
CHIX:AMSl's Days Sales Outstanding is ranked worse than 57.9% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.25
vs CHIX:AMSl: 71.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Days Sales Outstanding Chart
CHIX:AMSL vs ISRG, BDX, RMD: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Days Sales Outstanding falls into.
Advanced Medical Solutions Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group (CHIX:AMSL) has a Days Sales Outstanding of 68.38 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Advanced Medical Solutions Group and its competitors. This is near median its historical median of 63.20. Over the past decade, Advanced Medical Solutions Group's Days Sales Outstanding has ranged from 43.48 to 91.02. According to the industry distribution chart, Advanced Medical Solutions Group ranks #469 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 57.9%.
Is Advanced Medical Solutions Group's Days Sales Outstanding too high?
Advanced Medical Solutions Group's current Days Sales Outstanding of 68.38 is near median its 10-year median of 63.20. Over the past 10 years, this metric has ranged from a low of 43.48 to a high of 91.02. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.25. Advanced Medical Solutions Group's value of 68.38 is 4.8% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #469 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #469 out of 810 companies for Days Sales Outstanding. This places Advanced Medical Solutions Group in the lower half of its industry. The industry median Days Sales Outstanding is 65.25. Advanced Medical Solutions Group's value of 68.38 is 4.8% above this benchmark. Historically, Advanced Medical Solutions Group's own Days Sales Outstanding has ranged from 43.48 to 91.02 over the past decade. While the company's 10-year median is 63.20 vs. the industry median of 65.25, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.25, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Days Sales Outstanding of 68.38 is 4.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Days Sales Outstanding is 68.38, which is near median its own 10-year median of 63.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.75, compared to a current price of £2.81 — trading 25% below its estimated fair value. The current Days Sales Outstanding is 68.38, which is near median its 10-year median of 63.20 and 4.8% above the Medical Devices & Instruments industry median of 65.25. Advanced Medical Solutions Group's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Days Sales Outstanding is 68.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.81 is trading 25% below its estimated GF Value™ of £3.75.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Days Sales Outstanding: 68.38 (near median its 10-year median of 63.20)
GF Value™: £3.75 vs. price of £2.81 (25% below fair value)
Industry Position: 4.8% above the Medical Devices & Instruments median (#469 of 810)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
77GF Score
Get the complete analysis for CHIX:AMSL
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
